Filed 1mo ago· Apr 14, 2026
26 days to disclose
John Boozman
RSenateArkansas
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+1.3% vs S&P 500
Trade dateMar 19, 2026
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–10 of 10
Filed 5mo ago· Dec 8, 2025
17 days to discloseJohn Boozman
RSenateArkansas
↓sold
Eli Lilly
LLY
$1K-$15K
−3.9% vs S&P 500
Trade dateNov 21, 2025
Filed 8mo ago· Sep 12, 2025
21 days to discloseJohn Boozman
RSenateArkansas
↑bought
Eli Lilly
LLY
$1K-$15K
+40.8% vs S&P 500
Trade dateAug 22, 2025
Filed 8mo ago· Sep 12, 2025
21 days to discloseJohn Boozman
RSenateArkansas
↓sold
AbbVie
ABBV
$1K-$15K
+7.5% vs S&P 500
Trade dateAug 22, 2025
Filed 8mo ago· Sep 12, 2025
32 days to discloseJohn Boozman
RSenateArkansas
↓sold
AbbVie
ABBV
$1K-$15K
+14.0% vs S&P 500
Trade dateAug 11, 2025
Filed 8mo ago· Sep 12, 2025
32 days to discloseJohn Boozman
RSenateArkansas
↑bought
Eli Lilly
LLY
$1K-$15K
+52.2% vs S&P 500
Trade dateAug 11, 2025
Filed 1.1y ago· May 14, 2025
28 days to discloseJohn Boozman
RSenateArkansas
↓sold
Gilead Sciences
GILD
$1K-$15K
+9.0% vs S&P 500
Trade dateApr 16, 2025
Filed 1.2y ago· Mar 6, 2025
21 days to discloseJohn Boozman
RSenateArkansas
↓sold
Pfizer
PFE
$1K-$15K
+1.4% vs S&P 500
Trade dateFeb 13, 2025
Filed 2.4y ago· Jan 8, 2024
19 days to discloseJohn Boozman
RSenateArkansas
↑bought
Pfizer
PFE
$1K-$15K
−15.9% vs S&P 500
Trade dateDec 20, 2023
Filed 2.4y ago· Jan 8, 2024
19 days to discloseJohn Boozman
RSenateArkansas
↑bought
Pfizer
PFE
$1K-$15K
−15.9% vs S&P 500
Trade dateDec 20, 2023
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Apr 14, 2026 1mo ago | John Boozman RSenateArkansas | ↓sold | Johnson & Johnson JNJ | Mar 19, 2026 26 days to disclose | Flat·+0.0% +1.3% vs S&P 500 | $1K-$15K midpoint $8K |
Dec 8, 2025 5mo ago | John Boozman RSenateArkansas | ↓sold | Eli Lilly LLY | Nov 21, 2025 17 days to disclose | Flat·+0.0% −3.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | John Boozman RSenateArkansas | ↑bought | Eli Lilly LLY | Aug 22, 2025 21 days to disclose | Good buy·+$3.9K+48.3% +40.8% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | John Boozman RSenateArkansas | ↓sold | AbbVie ABBV | Aug 22, 2025 21 days to disclose | Flat·+0.0% +7.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | John Boozman RSenateArkansas | ↓sold | AbbVie ABBV | Aug 11, 2025 32 days to disclose | Flat·+0.0% +14.0% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | John Boozman RSenateArkansas | ↑bought | Eli Lilly LLY | Aug 11, 2025 32 days to disclose | Good buy·+$5.3K+66.2% +52.2% vs S&P 500 | $1K-$15K midpoint $8K |
May 14, 2025 1.1y ago | John Boozman RSenateArkansas | ↓sold | Gilead Sciences GILD | Apr 16, 2025 28 days to disclose | Flat·+0.0% +9.0% vs S&P 500 | $1K-$15K midpoint $8K |
Mar 6, 2025 1.2y ago | John Boozman RSenateArkansas | ↓sold | Pfizer PFE | Feb 13, 2025 21 days to disclose | Flat·+0.0% +1.4% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 8, 2024 2.4y ago | John Boozman RSenateArkansas | ↑bought | Pfizer PFE | Dec 20, 2023 19 days to disclose | Bad buy·−$319-4.0% −15.9% vs S&P 500 | $1K-$15K midpoint $8K |
Jan 8, 2024 2.4y ago | John Boozman RSenateArkansas | ↑bought | Pfizer PFE | Dec 20, 2023 19 days to disclose | Bad buy·−$319-4.0% −15.9% vs S&P 500 | $1K-$15K midpoint $8K |